Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Nagk | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | Nagk | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA | CTD | PMID:36331819 | Nagk | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Nagk (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of NAGK mRNA | CTD | PMID:22206623 | Nagk | Rat | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | NAGK (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to NAGK protein | CTD | PMID:32991956 | Nagk | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of NAGK mRNA | CTD | PMID:25380136 | Nagk | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA | CTD | PMID:17942748 | Nagk | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA | CTD | PMID:17942748 | Nagk | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA | CTD | PMID:33387578 | Nagk | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NAGK mRNA | CTD | PMID:32109520 | Nagk | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nagk (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAGK mRNA | CTD | PMID:21570461 | Nagk | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA | CTD | PMID:20106945|PMID:21632981 | Nagk | Rat | 2,6-dimethoxyphenol | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization more ... | CTD | PMID:38598786 | Nagk | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of NAGK mRNA | CTD | PMID:21346803 | Nagk | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of NAGK mRNA | CTD | PMID:25380136 | Nagk | Rat | acrylamide | increases expression | ISO | Nagk (Mus musculus) | 6480464 | Acrylamide results in increased expression of NAGK mRNA | CTD | PMID:30807115 | Nagk | Rat | all-trans-retinoic acid | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Tretinoin results in increased expression of NAGK mRNA | CTD | PMID:33167477 | Nagk | Rat | benzo[a]pyrene | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to NAGK promoter] | CTD | PMID:19654925 | Nagk | Rat | benzo[a]pyrene | decreases methylation | ISO | NAGK (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of NAGK promoter | CTD | PMID:27901495 | Nagk | Rat | benzo[a]pyrene | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of NAGK mRNA | CTD | PMID:21632981 | Nagk | Rat | benzo[a]pyrene | increases expression | ISO | Nagk (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of NAGK mRNA | CTD | PMID:20713471|PMID:22228805 | Nagk | Rat | beta-lapachone | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of NAGK mRNA | CTD | PMID:38218311 | Nagk | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NAGK mRNA | CTD | PMID:25181051 | Nagk | Rat | bisphenol A | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | bisphenol A results in increased expression of NAGK protein | CTD | PMID:37567409 | Nagk | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NAGK mRNA | CTD | PMID:30816183|PMID:32528016|PMID:34947998 | Nagk | Rat | bisphenol AF | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of NAGK protein | CTD | PMID:34186270 | Nagk | Rat | carbon nanotube | decreases expression | ISO | Nagk (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of NAGK mRNA | CTD | PMID:25620056 | Nagk | Rat | cisplatin | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Cisplatin results in increased expression of NAGK mRNA | CTD | PMID:27594783 | Nagk | Rat | clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of NAGK mRNA | CTD | PMID:17602206 | Nagk | Rat | cobalt dichloride | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of NAGK mRNA | CTD | PMID:19376846 | Nagk | Rat | copper(II) sulfate | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of NAGK mRNA | CTD | PMID:19549813 | Nagk | Rat | coumarin | increases phosphorylation | ISO | NAGK (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of NAGK protein | CTD | PMID:35688186 | Nagk | Rat | cyclosporin A | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NAGK mRNA | CTD | PMID:20106945 | Nagk | Rat | cyproconazole | increases expression | ISO | Nagk (Mus musculus) | 6480464 | cyproconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | Nagk | Rat | dextran sulfate | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein] | CTD | PMID:35362542 | Nagk | Rat | dextran sulfate | increases expression | ISO | Nagk (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of NAGK protein | CTD | PMID:35362542 | Nagk | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of NAGK mRNA | CTD | PMID:21266533 | Nagk | Rat | dibutyl phthalate | decreases expression | ISO | Nagk (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of NAGK mRNA | CTD | PMID:17361019 | Nagk | Rat | dorsomorphin | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nagk | Rat | elemental selenium | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Selenium results in increased expression of NAGK mRNA | CTD | PMID:19244175 | Nagk | Rat | epoxiconazole | increases expression | ISO | Nagk (Mus musculus) | 6480464 | epoxiconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | Nagk | Rat | ethyl methanesulfonate | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of NAGK mRNA | CTD | PMID:23649840 | Nagk | Rat | Evodiamine | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein] | CTD | PMID:35362542 | Nagk | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of NAGK mRNA | CTD | PMID:24136188 | Nagk | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of NAGK mRNA | CTD | PMID:24793618 | Nagk | Rat | formaldehyde | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of NAGK mRNA | CTD | PMID:23649840 | Nagk | Rat | FR900359 | increases phosphorylation | ISO | NAGK (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of NAGK protein | CTD | PMID:37730182 | Nagk | Rat | furfural | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization more ... | CTD | PMID:38598786 | Nagk | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of NAGK mRNA | CTD | PMID:33387578 | Nagk | Rat | inulin | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAGK mRNA | CTD | PMID:36331819 | Nagk | Rat | ivermectin | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of NAGK protein | CTD | PMID:32959892 | Nagk | Rat | leflunomide | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | leflunomide results in decreased expression of NAGK mRNA | CTD | PMID:28988120 | Nagk | Rat | methyl methanesulfonate | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of NAGK mRNA | CTD | PMID:23649840 | Nagk | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Nagk (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NAGK mRNA | CTD | PMID:22776087 | Nagk | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NAGK mRNA | CTD | PMID:25380136 | Nagk | Rat | nickel atom | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | Nickel results in decreased expression of NAGK mRNA | CTD | PMID:23195993 | Nagk | Rat | ochratoxin A | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of NAGK mRNA | CTD | PMID:22124623 | Nagk | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of NAGK mRNA | CTD | PMID:22124623 | Nagk | Rat | okadaic acid | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of NAGK mRNA | CTD | PMID:38832940 | Nagk | Rat | paracetamol | affects expression | ISO | Nagk (Mus musculus) | 6480464 | Acetaminophen affects the expression of NAGK mRNA | CTD | PMID:17562736 | Nagk | Rat | paracetamol | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NAGK mRNA | CTD | PMID:22230336 | Nagk | Rat | pentachlorophenol | increases expression | ISO | Nagk (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of NAGK mRNA | CTD | PMID:23892564 | Nagk | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Nagk (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | Nagk | Rat | perfluorononanoic acid | increases expression | ISO | Nagk (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | Nagk | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Nagk (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | Nagk | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Nagk | Rat | perfluorooctanoic acid | increases expression | ISO | Nagk (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of NAGK mRNA | CTD | PMID:28558994 | Nagk | Rat | perfluorooctanoic acid | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of NAGK mRNA] | CTD | PMID:28558994 | Nagk | Rat | phenobarbital | multiple interactions | ISO | Nagk (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NAGK mRNA] | CTD | PMID:19482888 | Nagk | Rat | phenobarbital | increases expression | ISO | Nagk (Mus musculus) | 6480464 | Phenobarbital results in increased expression of NAGK mRNA | CTD | PMID:19482888 | Nagk | Rat | phenylmercury acetate | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of NAGK mRNA | CTD | PMID:26272509 | Nagk | Rat | phenylmercury acetate | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nagk | Rat | pirinixic acid | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Nagk | Rat | pirinixic acid | increases expression | ISO | Nagk (Mus musculus) | 6480464 | pirinixic acid results in increased expression of NAGK mRNA | CTD | PMID:18301758|PMID:23811191 | Nagk | Rat | potassium chromate | decreases expression | ISO | NAGK (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | Nagk | Rat | potassium chromate | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA | CTD | PMID:22079256 | Nagk | Rat | propiconazole | increases expression | ISO | Nagk (Mus musculus) | 6480464 | propiconazole results in increased expression of NAGK mRNA | CTD | PMID:22334560 | Nagk | Rat | resveratrol | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of NAGK mRNA | CTD | PMID:23557933 | Nagk | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NAGK protein | CTD | PMID:35544339 | Nagk | Rat | SB 431542 | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nagk | Rat | selenium atom | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Selenium results in increased expression of NAGK mRNA | CTD | PMID:19244175 | Nagk | Rat | sodium arsenite | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of NAGK mRNA | CTD | PMID:38568856 | Nagk | Rat | sodium chloride | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of more ... | CTD | PMID:38598786 | Nagk | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of NAGK mRNA | CTD | PMID:19281266 | Nagk | Rat | tetrachloromethane | decreases expression | ISO | Nagk (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of NAGK mRNA | CTD | PMID:31919559 | Nagk | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of NAGK mRNA | CTD | PMID:34492290 | Nagk | Rat | titanium dioxide | decreases methylation | ISO | Nagk (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of NAGK gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Nagk | Rat | triphenyl phosphate | affects expression | ISO | NAGK (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of NAGK mRNA | CTD | PMID:37042841 | Nagk | Rat | valproic acid | affects expression | ISO | Nagk (Mus musculus) | 6480464 | Valproic Acid affects the expression of NAGK mRNA | CTD | PMID:17963808 | Nagk | Rat | valproic acid | affects expression | ISO | NAGK (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NAGK mRNA | CTD | PMID:25979313 | Nagk | Rat | valproic acid | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NAGK mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369 | Nagk | Rat | valproic acid | multiple interactions | ISO | NAGK (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Nagk | Rat | vitamin E | increases expression | ISO | NAGK (Homo sapiens) | 6480464 | Vitamin E results in increased expression of NAGK mRNA | CTD | PMID:19244175 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















